Company Marizyme, Inc.

Equities

GBSX

US5703721028

Biotechnology & Medical Research

Delayed OTC Markets 13:22:27 2024-05-17 EDT 5-day change 1st Jan Change
0.09 USD +12.50% Intraday chart for Marizyme, Inc. +63.64% -10.09%

Business Summary

Marizyme, Inc. is a medical technology company. The Company is focused on cardiac and surgical care by delivering innovative solutions for coronary artery bypass graft (CABG) surgery and other surgical procedures. Its product DuraGraft, is a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, thereby reducing the incidence and complications of graft failure and improving clinical outcomes post bypass surgery. The Company’s product under development includes MATLOC and MAR-FG-001. MATLOC is a lab-on-chip digital screening and diagnostic device platform being developed for quantitative chronic kidney disease (CKD) assessment. The MAR-FG-001 is a tumescent solution base for fat grafting procedures that is used for plastic and cosmetic surgeries in which fat is transferred from one area of the body to another to correct a defect, replace injured tissue, or to make cosmetic enhancements.

Number of employees: 13

Sales per Business

USD in Million2022Weight2023Weight Delta
Life Science Technologies
100.0 %
0 100.0 % 1 100.0 % +176.60%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 1 100.0 % +176.60%

Managers

Managers TitleAgeSince
Chief Executive Officer 67 21-11-15
Director of Finance/CFO 39 21-12-20
Chairman 71 21-02-21
Chief Tech/Sci/R&D Officer 66 20-12-01
Chief Tech/Sci/R&D Officer 68 20-06-30
Public Communications Contact 33 21-12-22
Corporate Officer/Principal - 20-12-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 67 21-11-15
Chairman 71 21-02-21
Director/Board Member 65 18-12-13
Director/Board Member 59 22-04-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 131,793,088 116,713,747 ( 88.56 %) 0 88.56 %

Shareholders

NameEquities%Valuation
4,610,548 9.880 % 336 570 $
Bologna Family Restaurant SpA
8.698 %
4,058,897 8.698 % 296 299 $
2,555,640 5.476 % 186 562 $
2,294,097 4.916 % 167 469 $
2,294,097 4.916 % 167 469 $
2,294,097 4.916 % 167 469 $
1,346,410 2.885 % 98 288 $
BWL Investments Ltd.
1.388 %
647,759 1.388 % 47 286 $
528,052 1.132 % 38 548 $
445,344 0.9543 % 32 510 $

Company contact information

Marizyme, Inc.

555 Heritage Drive Suite 205

33458, Jupiter

+

http://www.marizyme.com
address Marizyme, Inc.(GBSX)
  1. Stock Market
  2. Equities
  3. GBSX Stock
  4. Company Marizyme, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW